These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4304446)

  • 1. Markers of rubella virus strains in RK13 cell culture.
    Fogel A; Plotkin SA
    J Virol; 1969 Feb; 3(2):157-63. PubMed ID: 4304446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of plaque formation by freshly isolated and laboratory strains of rubella virus].
    Desiatskova RG
    Vopr Virusol; 1977; (2):178-83. PubMed ID: 898894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rubella virus: role of interferon during infection of African green monkey kidney tissue cultures.
    Wong KT; Baron S; Ward TG
    J Immunol; 1967 Dec; 99(6):1140-9. PubMed ID: 4293995
    [No Abstract]   [Full Text] [Related]  

  • 4. An unusual plaque variant of rubella virus.
    Gould JJ; Laurence GD; Butler M
    J Hyg (Lond); 1972 Mar; 70(1):49-53. PubMed ID: 4622479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of RK-13, vervet monkey kidney and patas monkey kidney cell cultures for the isolation of rubella virus.
    Best JM; Banatvala JE
    J Hyg (Lond); 1967 Sep; 65(3):263-71. PubMed ID: 4964173
    [No Abstract]   [Full Text] [Related]  

  • 6. A microplaque reduction assay for human and mouse interferon.
    Campbell JB; Grunberger T; Kochman MA; White SL
    Can J Microbiol; 1975 Aug; 21(8):1247-53. PubMed ID: 240500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved potency assay of rubella vaccine: parameters for plaque formation.
    Umino Y
    J Virol Methods; 1995 Feb; 51(2-3):317-28. PubMed ID: 7738152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of interferon production as a marker in the development of a modified strain of foot-and-mouth disease virus.
    Sellers RF; Mowat GN; Bennett JH; Barr DA
    Arch Gesamte Virusforsch; 1968; 23(1):12-9. PubMed ID: 4300581
    [No Abstract]   [Full Text] [Related]  

  • 9. Vesicular stomatitis virus plaque production in monolayer cultures with liquid overlay medium: description and adaptation to a one-day, human interferon-plaque.
    Green JA; Stanton GJ; Goode J; Baron S
    J Clin Microbiol; 1976 Dec; 4(6):479-85. PubMed ID: 187619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel plaque method for attenuated rubella virus in Vero cell cultures. Brief report.
    Sato H; Albrecht P; Ennis FA
    Arch Virol; 1979; 59(3):281-4. PubMed ID: 110292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some factors affecting interferon production by foot-and-mouth disease virus in bovine tissue cultues.
    Sellers RF; Bennett JH; Mowat GN; Snowdon WA
    Arch Gesamte Virusforsch; 1968; 23(1):1-11. PubMed ID: 4300584
    [No Abstract]   [Full Text] [Related]  

  • 12. Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero).
    Desmyter J; Melnick JL; Rawls WE
    J Virol; 1968 Oct; 2(10):955-61. PubMed ID: 4302013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of a persistent rubella infection in a human cell line.
    Williams MP; Brawner TA; Riggs HG; Roehrig JT
    J Gen Virol; 1981 Feb; 52(Pt 2):321-8. PubMed ID: 6169785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the interaction between coxsackievirus A9 and HeLa cells. I. Plaque-forming ability of coxsackievirus A9 in HeLa cell cultures.
    Matsumoto M; Nakano M; Nishikawa F; Tagaya I
    Jpn J Med Sci Biol; 1976 Apr; 29(2):67-76. PubMed ID: 184325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of rubella virus strain differences associated with attenuation.
    Chantler JK; Lund KD; Miki NP; Berkowitz CA; Tai G
    Intervirology; 1993; 36(4):225-36. PubMed ID: 8169114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth and release of several alphaviruses in chick and BHK cells.
    Strauss EG; Lenches EM; Stamreich-Martin MA
    J Gen Virol; 1980 Aug; 49(2):297-307. PubMed ID: 6255069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A plaque method for rubella virus assay.
    ROZEE KR; GIVAN KF; KOANE FW; RHODES AJ
    Can Med Assoc J; 1963 Aug; 89(7):314-5. PubMed ID: 13982899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New simple dye-uptake assay for interferon.
    Imanishi J; Hoshino S; Hoshino A; Oku T; Kita M; Kishida T
    Biken J; 1981 Sep; 24(3):103-8. PubMed ID: 6175308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting the assay of bovine type I interferon on bovine embryonic lung cells.
    Rossi CR; Kiesel GK; Hoff EJ
    Am J Vet Res; 1980 Apr; 41(4):552-6. PubMed ID: 6157340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An attenuated rubella virus vaccine (Cendehill 51 strain) grown in primary rabbit kidney cells.
    Huygelen C; Peetermans J; Prinzie A
    Prog Med Virol; 1969; 11():107-25. PubMed ID: 4984707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.